订阅小程序
旧版功能

Final Overall Survival Analysis for the Phase II RECORD-3 Study of First-Line Everolimus Followed by Sunitinib Versus First-Line Sunitinib Followed by Everolimus in Metastatic RCC

J. J. Knox,C. H. Barrios,T. M. Kim,T. Cosgriff,V. Srimuninnimit,K. Pittman,R. Sabbatini,S. Y. Rha,T. W. Flaig,R. D. Page,J. T. Beck,F. Cheung,S. Yadav,P. Patel,L. Geoffrois,J. Niolat,N. Berkowitz, M. Marker, D. Chen,R. J. Motzer

Annals of Oncology（2017）

引用 80|浏览97
关键词
renal cell carcinoma,sequential targeted therapy,everolimus,sunitinib
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要